Drug Trial Radar · NCT07761117
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Last checked: Nov 19, 2026Latest source record: Sep 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
6,950
Planned (sponsor's estimate)
Start
Aug 24, 2026
Primary completion
Sep 3, 2029
Study completion Sep 3, 2029
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Aug 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled, multicenter study to investigate CV outcomes with elecoglipron compared with placebo, in adults with heart failure with preserved ejection fraction (HFpEF)/heart failure with mildly reduced ejection fraction (HFmrEF), irrespective of T2DM status, and who are on background dapagliflozin in addition to other background standard of care.
Conditions
- Heart Failure With Preserved Ejection Fraction (HFpEF)
- Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Interventions
ElecoglipronDrug
Elecoglipron tablet
PlaceboDrug
Placebo tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the effect of elecoglipron compared with placebo in reducing the risk of CV death or HHF/urgent HF visitTime frame: Up to 42 months
Locations
679 sites in 32 countries. Site status is shown where the registry gives one.
Research Site
Fairhope, Alabama · Recruiting
Research Site
Anchorage, Alaska · Not yet recruiting
Research Site
Gilbert, Arizona · Not yet recruiting
Research Site
Sun City, Arizona · Not yet recruiting
Research Site
Beverly Hills, California · Not yet recruiting
Research Site
Huntington Beach, California · Not yet recruiting
Research Site
Huntington Park, California · Not yet recruiting
Research Site
Loma Linda, California · Not yet recruiting
Research Site
Lomita, California · Recruiting
Research Site
Mather, California · Not yet recruiting
Research Site
Northridge, California · Not yet recruiting
Research Site
Palo Alto, California · Not yet recruiting
Research Site
Redding, California · Not yet recruiting
Research Site
San Diego, California · Not yet recruiting
Research Site
Tarzana, California · Withdrawn
Research Site
Colorado Springs, Colorado · Not yet recruiting
Research Site
New Haven, Connecticut · Not yet recruiting
Research Site
Bradenton, Florida · Withdrawn
Research Site
Hallandale, Florida · Not yet recruiting
Research Site
Jacksonville, Florida · Not yet recruiting
Research Site
Lakeland, Florida · Not yet recruiting
Research Site
Miami, Florida · Not yet recruiting
Research Site
Miami, Florida · Not yet recruiting
Research Site
Miami, Florida · Not yet recruiting
Research Site
Miami Lakes, Florida · Withdrawn
Research Site
Miami Lakes, Florida · Recruiting
Research Site
Ocala, Florida · Not yet recruiting
Research Site
Ocoee, Florida · Withdrawn
Research Site
Palmetto Bay, Florida · Not yet recruiting
Research Site
Riverview, Florida · Not yet recruiting
Research Site
Tampa, Florida · Not yet recruiting
Research Site
Atlanta, Georgia · Not yet recruiting
Research Site
Columbus, Georgia · Not yet recruiting
Research Site
Tucker, Georgia · Not yet recruiting
Research Site
Champaign, Illinois · Withdrawn
Research Site
Chicago, Illinois · Not yet recruiting
Research Site
Gurnee, Illinois · Not yet recruiting
Research Site
Melrose Park, Illinois · Not yet recruiting
Research Site
Moline, Illinois · Not yet recruiting
Research Site
Niles, Illinois · Not yet recruiting
Showing 40 of 679 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.